Clinical trial
Effectiveness of an Individualized Progressive Treatment for Expanding Sound Tolerance in Adults With Autism Spectrum Disorder: A Crossover Randomized Controlled Trial (RCT)
NCT07798297 is registered in ClinicalTrials.gov with University of Central Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of an Individualized Progressive Treatment for Expanding Sound Tolerance in Adults With Autism Spectrum Disorder: A Crossover Randomized Controlled Trial (RCT)
- Lead sponsor
- University of Central Florida
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 31, 2026
- Completion date
- June 30, 2028
- Enrollment
- 40 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
autism spectrum disorder (asd), hyperacusis, loudness hyperacusis